A citation-based method for searching scientific literature

Zhijian Wu, Hongyan Yang, Peter Colosi. Mol Ther 2010
Times Cited: 457







List of co-cited articles
1086 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.
Lucas B Harrington, David Burstein, Janice S Chen, David Paez-Espino, Enbo Ma, Isaac P Witte, Joshua C Cofsky, Nikos C Kyrpides, Jillian F Banfield, Jennifer A Doudna. Science 2018
315
4

Retinitis pigmentosa.
Dyonne T Hartong, Eliot L Berson, Thaddeus P Dryja. Lancet 2006
4

Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque.
K Tyler McCullough, Sanford L Boye, Diego Fajardo, Kaitlyn Calabro, James J Peterson, Christianne E Strang, Dibyendu Chakraborty, Sebastian Gloskowski, Scott Haskett, Steven Samuelsson,[...]. Hum Gene Ther 2019
44
9

In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
Benjamin Bakondi, Wenjian Lv, Bin Lu, Melissa K Jones, Yuchun Tsai, Kevin J Kim, Rachelle Levy, Aslam Abbasi Akhtar, Joshua J Breunig, Clive N Svendsen,[...]. Mol Ther 2016
189
4

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.
A Auricchio, G Kobinger, V Anand, M Hildinger, E O'Connor, A M Maguire, J M Wilson, J Bennett. Hum Mol Genet 2001
297
4

RNA editing with CRISPR-Cas13.
David B T Cox, Jonathan S Gootenberg, Omar O Abudayyeh, Brian Franklin, Max J Kellner, Julia Joung, Feng Zhang. Science 2017
669
4

Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.
Keiji Nishida, Takayuki Arazoe, Nozomu Yachie, Satomi Banno, Mika Kakimoto, Mayura Tabata, Masao Mochizuki, Aya Miyabe, Michihiro Araki, Kiyotaka Y Hara,[...]. Science 2016
606
4

Directed evolution of CRISPR-Cas9 to increase its specificity.
Jungjoon K Lee, Euihwan Jeong, Joonsun Lee, Minhee Jung, Eunji Shin, Young-Hoon Kim, Kangin Lee, Inyoung Jung, Daesik Kim, Seokjoong Kim,[...]. Nat Commun 2018
196
4

Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.
Wenhan Yu, Suddhasil Mookherjee, Vijender Chaitankar, Suja Hiriyanna, Jung-Woong Kim, Matthew Brooks, Yasaman Ataeijannati, Xun Sun, Lijin Dong, Tiansen Li,[...]. Nat Commun 2017
161
4

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.
Hilda Petrs-Silva, Astra Dinculescu, Qiuhong Li, Seok-Hong Min, Vince Chiodo, Ji-Jing Pang, Li Zhong, Sergei Zolotukhin, Arun Srivastava, Alfred S Lewin,[...]. Mol Ther 2009
288
4

Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation.
Antonia A Dominguez, Wendell A Lim, Lei S Qi. Nat Rev Mol Cell Biol 2016
460
4

Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Hiroshi Nishimasu, Xi Shi, Soh Ishiguro, Linyi Gao, Seiichi Hirano, Sae Okazaki, Taichi Noda, Omar O Abudayyeh, Jonathan S Gootenberg, Hideto Mori,[...]. Science 2018
415
4

A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing.
Ang Li, Ciaran M Lee, Ayrea E Hurley, Kelsey E Jarrett, Marco De Giorgi, Weiqi Lu, Karol S Balderrama, Alexandria M Doerfler, Harshavardhan Deshmukh, Anirban Ray,[...]. Mol Ther Methods Clin Dev 2018
55
7

CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.
Guo-Xiang Ruan, Elizabeth Barry, Dan Yu, Michael Lukason, Seng H Cheng, Abraham Scaria. Mol Ther 2017
150
4

One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.
Hui Yang, Haoyi Wang, Chikdu S Shivalila, Albert W Cheng, Linyu Shi, Rudolf Jaenisch. Cell 2013
4

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.
Steven J Gray, Stacey B Foti, Joel W Schwartz, Lavanya Bachaboina, Bonnie Taylor-Blake, Jennifer Coleman, Michael D Ehlers, Mark J Zylka, Thomas J McCown, R Jude Samulski. Hum Gene Ther 2011
191
4

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Randy J Chandler, Matthew C LaFave, Gaurav K Varshney, Niraj S Trivedi, Nuria Carrillo-Carrasco, Julien S Senac, Weiwei Wu, Victoria Hoffmann, Abdel G Elkahloun, Shawn M Burgess,[...]. J Clin Invest 2015
200
4

Systemic delivery of adeno-associated viral vectors.
Dongsheng Duan. Curr Opin Virol 2016
55
7

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Kevin D Foust, Emily Nurre, Chrystal L Montgomery, Anna Hernandez, Curtis M Chan, Brian K Kaspar. Nat Biotechnol 2009
834
4

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.
Federico Mingozzi, Janneke J Meulenberg, Daniel J Hui, Etiena Basner-Tschakarjan, Nicole C Hasbrouck, Shyrie A Edmonson, Natalie A Hutnick, Michael R Betts, John J Kastelein, Erik S Stroes,[...]. Blood 2009
194
4

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
749
4

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
362
4

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
353
4

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Seiichiro Mori, Lina Wang, Takamasa Takeuchi, Tadahito Kanda. Virology 2004
150
4

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Jean-Charles Nault, Shalini Datta, Sandrine Imbeaud, Andrea Franconi, Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati, Benjamin Verret, Jean-Frédéric Blanc,[...]. Nat Genet 2015
272
4

Adeno-associated virus antibody profiles in newborns, children, and adolescents.
Roberto Calcedo, Hiroki Morizono, Lili Wang, Robert McCarter, Jianping He, David Jones, Mark L Batshaw, James M Wilson. Clin Vaccine Immunol 2011
182
4

A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.
Virginie Monteilhet, Samir Saheb, Sylvie Boutin, Christian Leborgne, Philippe Veron, Marie-Françoise Montus, Philippe Moullier, Olivier Benveniste, Carole Masurier. Mol Ther 2011
108
4

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.
R W ATCHISON, B C CASTO, W M HAMMON. Science 1965
622
4

Adeno-associated virus (AAV) vectors in cancer gene therapy.
Jorge L Santiago-Ortiz, David V Schaffer. J Control Release 2016
82
4

An essential receptor for adeno-associated virus infection.
S Pillay, N L Meyer, A S Puschnik, O Davulcu, J Diep, Y Ishikawa, L T Jae, J E Wosen, C M Nagamine, M S Chapman,[...]. Nature 2016
224
4

Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
Cody S Lee, Elliot S Bishop, Ruyi Zhang, Xinyi Yu, Evan M Farina, Shujuan Yan, Chen Zhao, Zongyue Zheng, Yi Shu, Xingye Wu,[...]. Genes Dis 2017
237
4

Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity.
Yi Yu, Thomas C Leete, David A Born, Lauren Young, Luis A Barrera, Seung-Joo Lee, Holly A Rees, Giuseppe Ciaramella, Nicole M Gaudelli. Nat Commun 2020
57
7

AAV2 gene therapy readministration in three adults with congenital blindness.
Jean Bennett, Manzar Ashtari, Jennifer Wellman, Kathleen A Marshall, Laura L Cyckowski, Daniel C Chung, Sarah McCague, Eric A Pierce, Yifeng Chen, Jeannette L Bennicelli,[...]. Sci Transl Med 2012
282
4

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.
Luke A Gilbert, Max A Horlbeck, Britt Adamson, Jacqueline E Villalta, Yuwen Chen, Evan H Whitehead, Carla Guimaraes, Barbara Panning, Hidde L Ploegh, Michael C Bassik,[...]. Cell 2014
4

Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR.
Susan D'Costa, Veronique Blouin, Frederic Broucque, Magalie Penaud-Budloo, Achille François, Irene C Perez, Christine Le Bec, Philippe Moullier, Richard O Snyder, Eduard Ayuso. Mol Ther Methods Clin Dev 2016
51
7

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy.
Kenji Rowel Q Lim, Chantal Yoon, Toshifumi Yokota. J Pers Med 2018
32
12

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, Saya Shirai, Tokiko Ohkame, Tetsushi Sakuma, Michihiro Tanaka, Naoki Amano, Akira Watanabe, Hidetoshi Sakurai,[...]. Stem Cell Reports 2015
333
4

Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase.
Juanjuan Yuan, Yunqing Ma, Tao Huang, Yanhao Chen, Yuanzheng Peng, Bing Li, Jia Li, Yuchen Zhang, Bing Song, Xiaofang Sun,[...]. Mol Cell 2018
62
6

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
925
4

Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
Courtney S Young, Ekaterina Mokhonova, Marbella Quinonez, April D Pyle, Melissa J Spencer. J Neuromuscul Dis 2017
44
9

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.
Michael E Nance, Ruicheng Shi, Chady H Hakim, Nalinda B Wasala, Yongping Yue, Xiufang Pan, Tracy Zhang, Carolyn A Robinson, Sean X Duan, Gang Yao,[...]. Mol Ther 2019
30
13

Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population.
Vijaya L Simhadri, Joseph McGill, Shane McMahon, Junxia Wang, Haiyan Jiang, Zuben E Sauna. Mol Ther Methods Clin Dev 2018
122
4

Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
Yuta Nihongaki, Fuun Kawano, Takahiro Nakajima, Moritoshi Sato. Nat Biotechnol 2015
336
4



Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Jerry R Mendell, Nathalie Goemans, Linda P Lowes, Lindsay N Alfano, Katherine Berry, James Shao, Edward M Kaye, Eugenio Mercuri. Ann Neurol 2016
310
4

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.
Brett T Staahl, Madhurima Benekareddy, Claire Coulon-Bainier, Ashwin A Banfal, Stephen N Floor, Jennifer K Sabo, Cole Urnes, Gabriela Acevedo Munares, Anirvan Ghosh, Jennifer A Doudna. Nat Biotechnol 2017
162
4

Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction.
Luke W Koblan, Jordan L Doman, Christopher Wilson, Jonathan M Levy, Tristan Tay, Gregory A Newby, Juan Pablo Maianti, Aditya Raguram, David R Liu. Nat Biotechnol 2018
308
4

Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
Steven J Gray, Valerie Matagne, Lavanya Bachaboina, Swati Yadav, Sergio R Ojeda, R Jude Samulski. Mol Ther 2011
302
4

Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors.
P Colella, I Trapani, G Cesi, A Sommella, A Manfredi, A Puppo, C Iodice, S Rossi, F Simonelli, M Giunti,[...]. Gene Ther 2014
66
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.